Table 1 Baseline characteristics of patients receiving endovascular treatment
Variables | Number (%) |
|---|---|
Age, mean ± SD, y | 67.6 ± 11.2 |
Sex, male, n (%) | 124 (77.5) |
Vascular risk factors | |
 Hypertension, n (%) | 139 (86.9) |
 Dyslipidemia, n (%) | 107 (66.9) |
 Diabetes mellitus, n (%) | 61 (38.1) |
 Coronary artery disease, n (%) | 29 (18.1) |
 Chronic kidney disease, n (%) | 12 (7.5) |
Medication | |
 Aspirin, n (%) | 131 (81.9) |
 Clopidogrel, n (%) | 140 (87.5) |
 Cilostazol, n (%) | 27 (16.9) |
Stenotic artery | |
 Middle cerebral artery, n (%) | 68 (42.5) |
 Internal cerebral artery, n (%) | 49 (30.6) |
  C1-2 | 10 (20.4) |
  C3-4 | 12 (24.5) |
  C5 | 27 (55.1) |
 Vertebral artery, n (%) | 31 (19.4) |
 Basilar artery, n (%) | 12 (7.5) |
Symptom | |
 TIA | 42 (26.2) |
 Ischemic stroke | 118 (73.8) |
Duration from last attack to procedure, median (IQR), day | 21 (14—30) |